Position in BIIB
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,849,473
-$343,337 QoQ
Shares Held
8,560
-28.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#354
of 1,031 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $71,666,047 across 14 Drug Manufacturers - General names. BIIB ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
51,320 | $18,583,998 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
110,868 | $14,007,063 | |
| 3 | LLY |
ELI LILLY & Co
|
9,538 | $11,440,164 | |
| 4 | JNJ |
Johnson & Johnson
|
32,688 | $8,301,771 | |
| 5 | ABBV |
AbbVie Inc.
|
26,168 | $6,584,915 | |
| 6 | MRK |
Merck & Co., Inc.
|
33,549 | $4,311,046 | |
| 7 | BIIB |
Biogen Inc.
This page
|
8,560 | $1,849,473 | |
| 8 | PFE |
Pfizer Inc
|
73,381 | $1,767,014 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,849,473 | 8,560 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,192,810 | 11,961 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,499,058 | 14,200 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,380,270 | 24,131 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,412,782 | 27,174 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,663,206 | 26,770 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $4,377,946 | 28,629 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,530,449 | 28,531 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,240,826 | 26,921 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,112,279 | 19,071 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $5,074,997 | 19,612 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,379,707 | 17,041 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,833,226 | 13,457 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,617,170 | 13,010 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,442,543 | 23,265 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $6,224,037 | 23,311 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $5,052,613 | 24,775 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $5,954,504 | 28,274 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $8,062,751 | 33,606 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $10,898,227 | 38,511 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,503,144 | 38,996 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $11,353,094 | 40,583 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $10,292,200 | 42,033 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $11,274,010 | 39,742 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $12,398,802 | 46,342 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $14,184,897 | 44,835 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||